Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 139,371 | 111,378 | 173,152 | 196,360 | 112,643 |
| Cost of Goods | 81,997 | 61,961 | 87,582 | 82,722 | 53,485 |
| Gross Profit | 57,374 | 49,416 | 85,570 | 113,638 | 59,158 |
| Operating Expenses | 100,979 | 279,472 | 123,532 | 85,802 | 66,954 |
| Operating Income | -42,608 | -229,094 | -37,379 | 28,558 | -7,311 |
| Interest Expense | 12,039 | 11,522 | 20,692 | 1,221 | 1,171 |
| Other Income | 3,502 | 6,108 | 1,204 | 0 | 44 |
| Pre-tax Income | -51,146 | -234,509 | -56,868 | 27,337 | -8,438 |
| Income Tax | 1,454 | -5,430 | -1,011 | 1,195 | -420 |
| Net Income Continuous | -52,600 | -229,079 | -55,857 | 26,142 | -8,019 |
| Minority Interests | -5,864 | -33,177 | -7,424 | N/A | N/A |
| Net Income | $-46,736 | $-195,902 | $-48,433 | $26,142 | $-8,019 |
| EPS Basic Total Ops | -0.45 | -2.03 | -0.51 | 0.31 | -0.10 |
| EPS Basic Continuous Ops | -0.51 | -2.37 | -0.59 | 0.31 | -0.10 |
| EPS Diluted Total Ops | -0.45 | -2.03 | -0.51 | 0.31 | -0.10 |
| EPS Diluted Continuous Ops | -0.51 | -2.37 | -0.59 | 0.31 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -2.03 | -0.51 | 0.31 | -0.10 |
| EBITDA(a) | $-18,339 | $-193,382 | $-4,048 | $45,686 | $5,322 |